Trials / Conditions / Melanoma of Unknown Primary

Melanoma of Unknown Primary

8 registered clinical trials studyying Melanoma of Unknown Primary.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Bra NCT05341349	Emory University	Phase 1
Active Not Recruiting	A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment i NCT04708418	National Cancer Institute (NCI)	Phase 2
Terminated	Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement NCT04221438	ECOG-ACRIN Cancer Research Group	Phase 2
Active Not Recruiting	Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV NCT04462406	ECOG-ACRIN Cancer Research Group	Phase 2
Completed	Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melano NCT03033576	National Cancer Institute (NCI)	Phase 2
Completed	Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases NCT02858869	Emory University	Phase 1
Completed	A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV NCT02129075	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has NCT01274338	National Cancer Institute (NCI)	Phase 3